However, as CD86 expression was not affected, as shown by flow cytometry, and IL-6 expression was not significantly different, as shown by RT–qPCR, we could conclude only that BC Sealer HiFlow and iRoot SP promoted M2-like macrophage polarization. This evidence concerns the gene CD86 and breast cancer.